TD Asset Management’s BioAmber Inc. BIOA Stock Holding History

TD Asset Management’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-380,893	Closed	-$977K	–	1354
2017 Q2	$977K	Buy	+380,893	New	+$875K	﹤0.01%	1049

Other funds holding BIOA

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TD Asset Management's BIOA Position: Q3 2017 in Review

TD Asset Management sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 380,893 shares — an estimated $977K sold.

TD Asset Management first reported a position in BIOA in Q2 2017 and held it in 1 quarter. The position peaked at $977K in Q2 2017. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

TD Asset Management reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
TD Asset Management sold 380,893 BioAmber Inc. shares in Q3 2017, an estimated $977K.
TD Asset Management first reported a position in BioAmber Inc. in Q2 2017 and held it in 1 quarter.
TD Asset Management's BioAmber Inc. position peaked at $977K in Q2 2017.
30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on TD Asset Management's 13F filing for Q3 2017, filed 9 Nov 2017.